Compare IQ & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQ | AORT |
|---|---|---|
| Founded | 2009 | 1984 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | 2018 | 1993 |
| Metric | IQ | AORT |
|---|---|---|
| Price | $2.02 | $45.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $2.87 | ★ $49.36 |
| AVG Volume (30 Days) | ★ 10.1M | 355.3K |
| Earning Date | 11-18-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,808,085,043.00 | $422,646,000.00 |
| Revenue This Year | N/A | $15.97 |
| Revenue Next Year | $2.72 | $10.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.81 |
| 52 Week Low | $1.50 | $21.97 |
| 52 Week High | $2.84 | $48.04 |
| Indicator | IQ | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 40.98 | 52.23 |
| Support Level | $1.97 | $42.68 |
| Resistance Level | $2.08 | $46.02 |
| Average True Range (ATR) | 0.07 | 1.35 |
| MACD | -0.00 | -0.25 |
| Stochastic Oscillator | 20.00 | 56.87 |
Iqiyi is a leading streaming video-on-demand company in China that generates revenue mostly through a subscription basis. The platform also provides user-generated content to nonpaying users, monetized through ads. The company self-produces much of the subscription content and also generates revenue through content distribution, gaming, and IP licensing. Iqiyi competes directly with Tencent Video, Alibaba's Youku, ByteDance's MangoTV, and Bilibili. The company is 45% and 5% owned by Baidu and Xiaomi, respectively.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.